Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03417544
Title Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Nancy Lin, MD
Indications

Her2-receptor positive breast cancer

Therapies

Atezolizumab + Pertuzumab + Trastuzumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST